Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients

PURPOSE: Corticosteroids, in particular dexamethasone, are one of the primary treatment options for critically ill COVID-19 patients. However, there are a growing number of cases that involve COVID-19-associated pulmonary aspergillosis (CAPA), and it is unclear whether dexamethasone represents a ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Leistner, Rasmus, Schroeter, Lisa, Adam, Thomas, Poddubnyy, Denis, Stegemann, Miriam, Siegmund, Britta, Maechler, Friederike, Geffers, Christine, Schwab, Frank, Gastmeier, Petra, Treskatsch, Sascha, Angermair, Stefan, Schneider, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796178/
https://www.ncbi.nlm.nih.gov/pubmed/35090528
http://dx.doi.org/10.1186/s13054-022-03902-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796178/
https://www.ncbi.nlm.nih.gov/pubmed/35090528
http://dx.doi.org/10.1186/s13054-022-03902-8

Ejemplares similares